Arrowsmith

Biotechnology Research • 27 Miyukigaoka, SakuLab-Tsukuba, Japan • 1-10 Employees

Company overview

Headquarters	27 Miyukigaoka, SakuLab-Tsukuba, Tsukuba, Ibaraki 3050841, JP
NAICS	541714
Keywords	Biotechnology, AMR, Infectious Diseases, Synthetic Biology, Phage Therapy, New Modalities
Founded	2025
Employees	1-10

Key Contact at Arrowsmith

Kazuyuki Sakamoto

Co‑founder & COO

About Arrowsmith

Arrowsmith Inc. is a research-driven biotech focused on bringing next-generation bacteriophage therapy into clinical use for patients suffering from antibiotic-resistant and difficult-to-treat bacterial infections. With the vision of "Delivering safe and effective phage therapy worldwide, creating a future free from bacterial infections", we relentlessly pursue R&D for innovative solutions, leveraging the outcomes of our academia-industry collaboration.

Arrowsmith revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Arrowsmith has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Arrowsmith has never raised funding before.

Frequently asked questions

Arrowsmith is located in 27 Miyukigaoka, SakuLab-Tsukuba, JP.

Arrowsmith was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.

Arrowsmith has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Arrowsmith

Kazuyuki Sakamoto

Co‑founder & COO

4.8

40,000 users